carbocysteine has been researched along with Disease Exacerbation in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Calzetta, L; Cazzola, M; Hanania, NA; Matera, MG; Rogliani, P | 1 |
| Huang, X; Xiao, Z; Yang, D; Zeng, Z | 1 |
| Fukuchi, Y; Tatsumi, K | 1 |
2 review(s) available for carbocysteine and Disease Exacerbation
| Article | Year |
|---|---|
Impact of Mucolytic Agents on COPD Exacerbations: A Pair-wise and Network Meta-analysis.
Topics: Acetylcysteine; Ambroxol; Carbocysteine; Disease Progression; Expectorants; Humans; Network Meta-Analysis; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic; Thioglycolates; Thiophenes | 2017 |
Effect of carbocisteine on patients with COPD: a systematic review and meta-analysis.
Topics: Carbocysteine; Chi-Square Distribution; Disease Progression; Expectorants; Forced Expiratory Volume; Humans; Lung; Odds Ratio; Pulmonary Disease, Chronic Obstructive; Quality of Life; Randomized Controlled Trials as Topic; Treatment Outcome | 2017 |
1 trial(s) available for carbocysteine and Disease Exacerbation
| Article | Year |
|---|---|
Carbocisteine improves quality of life in patients with chronic obstructive pulmonary disease.
Topics: Administration, Inhalation; Aged; Bronchodilator Agents; Carbocysteine; Common Cold; Disability Evaluation; Disease Progression; Drug Therapy, Combination; Expectorants; Forced Expiratory Volume; Humans; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Quality of Life; Vital Capacity | 2007 |